Liquid biopsy can help predict outcomes in metastatic triple-negative breast cancer

A clinically relevant "liquid biopsy" test can be used to profile cancer genomes from blood and predict survival outcomes for patients with metastatic triple negative breast cancer (TNBC), according to new research published in the Journal of Clinical...

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2C77rki
via IFTTT